Student：Huang Yanhong, Translation and Interpreting Major

The Key Laboratory of Thalassemia Prevention and Control， CAMS founded in Guangxi Medical University

Source: The Publicity Department, Guangxi Medical University

Release Date: December 11, 2017

On the morning of December 9, 2017, the Key Laboratory of Thalassemia Prevention and Control, Chinese Academy of Medical Sciences (CAMS), was founded in Guangxi Medical University. Many doctors and specialists attended the opening ceremony, including Huang Ribo, vice-chairman of the Peolple’s Government of Guangxi Zhuang Autonomous Region and also the president of Guangxi Academy of Sciences, Liu Depei, an advisor of chairman of Guangxi Government and former vice-president of Chinese Academy of Engineering, Zhang Xue, vice-president of CAMS, vice-president of Peking Union Medical College and also a specialist invited by Guangxi government, and other officials from Guangxi Health and Family Planning Commission, Guangxi Education Department, Guangxi Science and Technology Department, Guangxi Association for Science and Technology and the leaders of Guangxi Medical University as well.

On the opening ceremony, on behalf of the President of Chinese Academy of Medical Sciences and President of Peking Union Medical College, Prof. Zhang Xue announced the approval of Founding the Key Laboratory of Thalassemia Prevention and Control, CAMS and awarded the letters of appointment to the Director of the Laboratory and the Director of Academic Committee. Afterward, all the participating experts and leaders jointly unveiled the nameplate of the Key Laboratory of Thalassemia Prevention and Control, Chinese Academy of Medical Sciences (CAMS).

Thalassemia is a genetic and hemolytic disease, occurring relatively often in Mediterranean regions, Southeast Asian regions and Southern China. Having serious impact on population quality, bringing a heavy burden on families and society, it has become a public health issue that affects social harmony and development. The government of Guangxi has attached great importance to the study of Thalassemia prevention and control. Since 2010, the academician Liu Depei has been appointed as an advisor of Guangxi government’s Chairman and Prof. Zhang Xue, as a special expert to support and promote the comprehensive implementation of the "thalassemia prevention and control plan" in Guangxi, and has promoted the implementation of 2014 Thalassemia Prevention and Control Coverage Project of National Health and Family Planning Commission based on Guangxi intervention Model in the 10 provinces(cities) with high incidence of Thalassemia in the Southern China. It plays an important part in lowering the birth defects and improving the population quality.

As the center of medical education, clinical medical research and health care in Guangxi, Guangxi Medical University fully implements the national policies and guidance in the fields of education, health care, science and technology. Since 1950s, it has already conducted researches about Thalassemia control, and carried out the researches on genetic diagnosis of thalassemia, early prenatal diagnosis and abnormal hemoglobin with Chinese Academy of Medical Sciences Institute of Basic Medical Sciences in the late 1970s. It has undertaken more than 40 scientific projects of Ministry of Science and Technology, National Natural Science Foundation of China, National Health and Family Planning Commission and Department of Science and Technology of Guangxi. It has obtained great achievements and widely applied in Thalassemia clinical diagnosis and prevention. In recent five years, about 8000000 cases of thalassemia has been screened and diagnosed in Guangxi, and more than 6000 cases of children with severe thalassemia have been avoided, and the incidence of birth defect is greatly reduced to 11.26%, which contributes a lot to the society. It has won more than 20 national and provincial scientific achievement awards, such as the Second Prize for Science& Technology Achievement of the Ministry of Health P. R. China, the Song Qingling Pediatrics Prize and the First Prize for Science& Technology Achievement of Guangxi. In 2013, the Science magazine focused on its news coverage of Guangxi Medical University’s research on Thalassemia prevention and control, and the Chinese government’s prevention and control plan.

In accordance with the development strategy of Healthy China raised by the CPC 19th National Congress, and to meet the needs for the development of  higher education and medical health service in this new age, the Key Laboratory of Thalassemia Prevention and Control, CAMS in Guangxi Medical University (GMU), will bring high-level talents together under the principle of open, mobility, union, and competition, carry out innovative researches and produce a number of landmark achievements. It will enhance its competitive power and innovation ability, strengthen the exchanges and cooperation with high incidence areas of Thalassemia along the One Belt and One Road of, and take great efforts to build the laboratory as a higher-level clinic research base, as well as a Silk Road for Health, to serve the Southern China, Southeast Asian countries with  high incidence of Thalassemia.

After the opening ceremony,　in the accompany of GMU’s general secretary Liu Youyi and the president Zhao Jinmin, the attendees visited the Key Laboratory of Thalassemia Prevention and Control of CAMS, Regenerative Medicine Laboratory and Guangxi Medical University Regenerative Medicine and Cooperative Medical Technology Co Ltd.

中国医学科学院地中海贫血防治研究重点实验室在广西医科大学挂牌

来源：宣传部  发布时间：2017-12-11  作者:韦杨  点击量：

2017年12月9日上午,“中国医学科学院地中海贫血防治研究重点实验室”在广西医科大学正式挂牌。广西政府副主席、广西科学院院长黄日波，广西政府主席院士顾问、原中国工程院副院长刘德培院士，广西特聘专家、中国医学科学院、北京协和医学院张学副院校长，广西卫计委李国坚主任、广西教育厅唐耀华巡视员、广西科技厅黎卫红副巡视员、广西科协副主席何求和广西医科大学党委刘友谊书记、赵劲民校长、曾志羽副校长、伍伟锋副校长等专家、领导出席揭牌仪式。

揭牌仪式上，张学副院校长代表曹雪涛院校长致辞并宣读《关于同意建设中国医学科学院地中海贫血防治研究重点实验室的通知》，为实验室主任和学术委员会主任颁发聘书。随后，全体与会专家领导共同为“中国医学科学院地中海贫血防治研究重点实验室”揭牌。

地中海贫血是遗传性溶血性疾病，广泛流行于地中海、东南亚和中国南方等地，严重影响人口素质，给家庭和社会带来沉重的负担，成为影响社会和谐和发展的公共卫生问题。广西政府非常重视地中海贫血防治研究工作，2010年起聘任刘德培院士为政府主席院士顾问、张学教授为特聘专家，支持和促进广西全面实施“地中海贫血防治计划”，并推动了国家卫生计生委自2014年起以广西的干预模式在南方十个省（市）地中海贫血高发区实施“地中海贫血防治全覆盖项目”，为国家降低出生缺陷，提高人口素质起到了重要的作用。

作为广西医学教育、医学研究、临床医疗和预防保健中心的广西医科大学，认真贯彻落实党和政府的教育、医疗卫生和科技方面的方针政策，在上个世纪50年代就已开展地中海贫血防治研究，70年代末期与中国医学科学院基础医学研究所合作开展了地中海贫血基因诊断及早期产前诊断、异常血红蛋白症等研究，先后承担了40多项国家科技部、国家自然科学基金委员会、国家卫生计生委和广西科技厅等科研课题，取得了很好的成果，广泛应用于临床地中海贫血的防治，近五年，共对广西地中海贫血筛查和诊断800多万人次，避免了6000多例重型地中海贫血患儿出生，使出生缺陷大幅度降低至11.26%，产生了良好的社会效益，获得卫生部科技进步奖二等奖、宋庆龄儿科医学奖、广西科技进步奖一等奖等国家和省部级科研成果奖20余项。Science杂志于2013年以焦点新闻报道了广西医科大学开展地中海贫血防治的研究工作和中国政府的防治计划。

党的十九大报告提出，要“大力实施健康中国发展战略”。按照中央和国家新时代高等教育发展与医疗卫生事业发展新要求，“中国医学科学院地中海贫血防治研究重点实验室”将在“开放、流动、联合、竞争”的运行机制下，汇聚高层次高水平人才队伍，开展创新性研究，形成一批标志性成果，不断增强重点实验室的综合竞争力和原始创新能力，加强与“一带一路”沿线地中海贫血高发国家和地区的交流与合作，努力将实验室建成服务于我国南方及东南亚国家等地中海贫血高发地区的高水平科研及临床基地，切实打造“健康丝绸之路”。

揭牌仪式后，与会专家在刘友谊书记和赵劲民校长的陪同下实地考察了中国医学科学院地中海贫血防治研究重点实验室、再生医学实验室及广西医大再生医学协同医疗技术有限公司。